These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 38310397
1. Pharmacokinetics of Anti-rheumatic Drugs Methotrexate and Tofacitinib with its Metabolite M9 in Rats by UPLC-MS/MS. Gu EM, Xue L, Zhou C, Xia Y, Dai GX. Curr Med Chem; 2024; 31(22):3426-3435. PubMed ID: 38310397 [Abstract] [Full Text] [Related]
2. Simultaneous measurement of upadacitinib and methotrexate by UPLC-MS/MS and its pharmacokinetic application in rats. Li J, Chen C, Wang J, Ye Z, Pan L, Liu Z, Tang C. J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Jan 01; 1188():123071. PubMed ID: 34875493 [Abstract] [Full Text] [Related]
3. A validated LC-MS/MS assay for simultaneous quantification of methotrexate and tofacitinib in rat plasma: application to a pharmacokinetic study. Sharma K, Giri K, Dhiman V, Dixit A, Zainuddin M, Mullangi R. Biomed Chromatogr; 2015 May 01; 29(5):722-32. PubMed ID: 25298296 [Abstract] [Full Text] [Related]
4. Development and validation of a rapid and sensitive UPLC-MS/MS assay for the quantification of tofacitinib in human plasma. Bharwad KD, Shah PA, Shrivastav PS, Singhal P. Biomed Chromatogr; 2019 Apr 01; 33(4):e4458. PubMed ID: 30520053 [Abstract] [Full Text] [Related]
5. Simultaneous quantification and pharmacokinetic investigation of selexipag and its main metabolite ACT-333679 in rat plasma by UPLC-MS/MS method. Xie S, Shi L, Chen J, Xu RA, Ye X. J Pharm Biomed Anal; 2020 Oct 25; 190():113496. PubMed ID: 32768890 [Abstract] [Full Text] [Related]
6. Simultaneous determination of bentysrepinine (Y101) and its metabolites M8 and M9 in human plasma by UPLC-MS/MS and its application to a pharmacokinetic study. Liu X, Huang C, Xue L, Xu Q, Xia W, Li X, Miao L. J Pharm Biomed Anal; 2018 Feb 20; 150():287-293. PubMed ID: 29258048 [Abstract] [Full Text] [Related]
7. Determination of kurarinone in rat plasma by UPLC-MS/MS. Zhang WM, Li RF, Qiu JF, Zhang ZY, Wang HB, Bian L, Lei JH. J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Apr 01; 986-987():31-4. PubMed ID: 25703950 [Abstract] [Full Text] [Related]
8. Validated UPLC/MS/MS assay for quantitative bioanalysis of elbasvir in rat plasma and application to pharmacokinetic study. Liu H, Xu H, Song W, Zhang Y, Yu S, Huang X. J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Mar 15; 1015-1016():150-156. PubMed ID: 26927874 [Abstract] [Full Text] [Related]
9. Determination of cephalomannine in rat plasma by gradient elution UPLC-MS/MS method. Wang XS, Sun JC, Yang RN, Ren J, Liang S, Sun M, Wang YF, Gao SG. J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jul 15; 963():70-4. PubMed ID: 24929960 [Abstract] [Full Text] [Related]
10. Determination of Pralsetinib in Human Plasma and Cerebrospinal Fluid for Therapeutic Drug Monitoring by Ultra-performance Liquid Chromatography-Tandem Mass Spectrometry (UPLC-MS/MS). Zhao Z, Pu Q, Sun T, Huang Q, Tong L, Fan T, Kang J, Chen Y, Zhang Y. Anticancer Agents Med Chem; 2024 Jul 15; 24(11):867-877. PubMed ID: 38584556 [Abstract] [Full Text] [Related]
11. Simultaneous determination of nintedanib and its metabolite by UPLC-MS/MS in rat plasma and its application to a pharmacokinetic study. Lin D, Qiao LM, Zhang YN, Liu Y, Liu XS. J Pharm Biomed Anal; 2016 Jan 05; 117():173-7. PubMed ID: 26355771 [Abstract] [Full Text] [Related]
12. Quantitative bioanalytical assay for the human epidermal growth factor receptor (HER) inhibitor dacomitinib in rat plasma by UPLC-MS/MS. Qiu X, Lin Q, Ning Z, Qian X, Li P, Ye L, Xie S. J Pharm Biomed Anal; 2019 Mar 20; 166():66-70. PubMed ID: 30612075 [Abstract] [Full Text] [Related]
13. Determination and pharmacokinetic study of pirfenidone in rat plasma by UPLC-MS/MS. Sun W, Jiang ZL, Zhou L, Chen RM, Wang Z, Li WS, Jiang SM, Hu GX, Chen RJ. J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Feb 15; 981-982():14-8. PubMed ID: 25596380 [Abstract] [Full Text] [Related]
14. Determination of acacetin in rat plasma by UPLC-MS/MS and its application to a pharmacokinetic study. Fan LH, Li X, Chen DY, Zhang N, Wang Y, Shan Y, Hu Y, Xu RA, Jin J, Ge RS. J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Apr 01; 986-987():18-22. PubMed ID: 25703948 [Abstract] [Full Text] [Related]
15. Simultaneous determination of 11 alkaloids in rat plasma by LC-ESI-MS/MS and a pharmacokinetic study after oral administration of total alkaloids extracted from Naucleaofficinalis. Wang G, Wang H, Lin Z, Hou L, Wang JY, Sun L. J Ethnopharmacol; 2022 Jan 10; 282():114560. PubMed ID: 34454053 [Abstract] [Full Text] [Related]
16. UPLC-MS/MS method for determination of avicularin in rat plasma and its application to a pharmacokinetic study. Zhang WM, Li RF, Sun M, Hu DM, Qiu JF, Yan YH. J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Aug 15; 965():107-11. PubMed ID: 25010713 [Abstract] [Full Text] [Related]
17. Development of an UPLC-MS/MS Method for the Quantitative Analysis of Upadacitinib in Beagle Dog Plasma and Pharmacokinetics Study. Wang MJ, Zhao YH, Fan C, Wang YJ, Wang XQ, Qiu XJ, Shen RL. Drug Des Devel Ther; 2021 Aug 15; 15():4167-4175. PubMed ID: 34629864 [Abstract] [Full Text] [Related]
19. Determination of xanthatin by ultra high performance liquid chromatography coupled with triple quadrupole mass spectrometry: application to pharmacokinetic study of xanthatin in rat plasma. Yan C, Li H, Wu Y, Xie D, Weng Z, Cai B, Liu X, Li W, Chen Z. J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Feb 01; 947-948():57-61. PubMed ID: 24389355 [Abstract] [Full Text] [Related]